Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
Weight loss drugs are incredibly sought-after, but they’re also often difficult to obtain due to limited insurance coverage ...
SA People on MSN2d
Caution issued regarding the purchase of fake OzempicSAHPRA cautions the public to not purchase and/or consume such products as their safety, efficacy, and quality have not been ...
These pose a health risk to the public. Sahpra cautions the public to not purchase and/or consume such products as their ...
According to the watchdog, Ozempic in South Africa is registered under two presentations of pre-filled injectable pens, ...
The SA Health Products Regulatory Authority has expressed concern at the increasing presence of counterfeit products such as ...
People living with type 1 diabetes need to inject insulin several times a day to stay ... of its patented GLP-1 medicine for diabetes and obesity (marketed as Ozempic and Wegovy) in pen devices at ...
Yes, it’s technically possible to overdose on Ozempic—but it’s unlikely, says Alexandra Sowa, MD, an internal medicine doctor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback